Cited by 53Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementAdvanced Proteomics Techniques and Applications

Identification and validation of novel serum markers for early diagnosis of endometriosis

Gajbhiye, R., Sonawani, A., Khan, S., Suryawanshi, A., Kadam, S., Warty, N., Raut, V., Khole, V.·2012·Human Reproduction

Abstract

BACKGROUND: Non-invasive diagnosis of endometriosis is urgently required to prevent the long delay between the onset of symptoms and diagnosis. A biomarker that possesses both high sensitivity and specificity is greatly required. Here, we describe the use of a proteomic approach to identify potential novel endometrial antigens using sera from endometriosis patients and healthy controls, with evaluation of biomarkers for non-invasive diagnosis of endometriosis. METHODS: A cross-sectional study was conducted to identify specific endometrial antigens using 1D and 2D western blots in women with early endometriosis (n = 17), advanced endometriosis (n = 23) and without endometriosis (n = 30). Five immunoreactive spots were analyzed using matrix-assisted laser desorption/ionization-time-of-flight/mass spectrometry with MASCOT analysis. ELISAs were established for specific epitopes and autoantibody titres were estimated in an independent cohort comprising women with early endometriosis (n = 18), advanced endometriosis (n = 32) and without endometriosis (n = 27) for validation. RESULTS: The 2D western blot analysis resulted in the identification of three endometrial antigens, tropomyosin 3 (TPM3), stomatin-like protein 2 (SLP2) and tropomodulin 3 (TMOD3). Serum levels of antibodies against the epitopes from the immunodominant region of proteins TPM3, SLP2 and TMOD3 were significantly elevated in endometriosis patients when compared with controls. Sensitivity and specificity of serum anti-TPM3a-autoAb (61%, 93%), anti-TPM3c-autoAb (44%, 93%), anti-TPM3d-autoAb (78%, 89%), anti-SLP2a-autoAb (50%, 96%), anti-SLP2c-autoAb (61%, 93%), anti-TMOD3b-autoAb (61%, 96%), serum anti-TMOD3c-autoAb (78%, 93%) and anti-TMOD3d-autoAb (78%, 96%) were better than those of serum CA125 levels (21%, 89%) in the detection of early stages of endometriosis. CONCLUSIONS: Serum anti-TPM3a-autoAb, anti-TPM3c-autoAb, anti-TPM3d-autoAb, anti-SLP2a-autoAb, anti-SLP2c-autoAb, anti-TMOD3b-autoAb, anti-TMOD3c-autoAb and anti-TMOD3d-autoAb could be new markers for the early diagnosis of endometriosis.

Integrity signals

Registry

Crossref · 10.1093/humrep/der410

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Autoantibodies against different epitopes of TPM3, SLP2, and TMOD3 were significantly elevated in serum of endometriosis patients with both minimal/mild and moderate/severe disease.

    “Autoantibodies against different epitopes of tropomyosin 3 (TPM3), stomatin-like protein 2 (SLP2), and tropomodulin 3 (TMOD3) were significantly elevated in the serum of endometriosis patients with both minimal/mild and moderate/severe disease [80].”

    From Update on biomarkers for the detection of endometriosis (2015) · cites this paper as [80]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gajbhiye, R., Sonawani, A., Khan, S., Suryawanshi, A., Kadam, S., Warty, N., Raut, V., & Khole, V.
Affiliations
  • ICMR National Institute for Research on Women's Health (IN)
  • Institute of Life Sciences (IN)
Corresponding author
Khole, V.
Venue
Human Reproduction
Published
2011-12-08
Volume
27
Issue
2
Pages
408-417
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2165441271
Cited by
53
References
46
Citations by year
2026: 2 · 2025: 6 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 4 · 2013: 6
FWCI
3.59
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Funders
Indian Council of Medical Research
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords
endometriosis, serum biomarkers, autoantibodies, early diagnosis, non-invasive diagnosis, TPM3, STOML2, CA125, proteomics, ELISA validation, sensitivity and specificity
MeSH terms
Adult, Antibody Specificity, Autoantibodies, Autoantigens, Blood Proteins, Cross-Sectional Studies, Endometriosis, Female, Humans, Membrane Proteins, Peptide Fragments, Peptide Mapping, Sensitivity and Specificity, Severity of Illness Index, Tropomyosin, Cohort Studies, Biomarkers, Immunodominant Epitopes, Early Diagnosis, Tropomodulin, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review